The Affordable Care Act (ACA) has led to increased guideline-concordant care for colon cancer among non-white patients, ...

aDepartment of Hematology/Oncology, Comprehensive Cancer Center (CCC Munich), LMU University Hospital Munich, 81377 Munich, Germany bDepartment of Hematology, Oncology, and Cancer Immunology (CCM), ...

Colon cancer is increasingly affecting the younger population. It's essential to be informed about the risk factors and ...

September is an important month for me because it is Ovarian Cancer Awareness Month. I am a 15-year survivor of ovarian ...

Amgen (NASDAQ: AMGN) today announced the presentation of new data across its broad oncology pipeline and portfolio at the ...

Pfizer Inc. (NYSE: PFE) continues to showcase potential practice-changing research and next-generation candidates across its ...

Colon cancer is the third most common cancer in males. How can it be prevented? Is it curable? To know the answers, read on.

expressing platinum-sensitive ovarian cancer (PSOC) (mini-oral presentation). Exploratory patient reported outcomes (PROs) from the Phase 2 LUMINOSITY trial, evaluating telisotuzumab vedotin (Teliso-V ...

New and updated data from an ongoing Phase 2 trial of zanidatamab, an investigational dual HER2-targeted bispecific antibody, in combination with chemotherapy for first-line treatment of HER2-positive ...

Colorectal cancer is a leading cause of cancer-related deaths worldwide. For patients with metastatic disease, treatment options are limited and the prognosis is often poor. Regorafenib, a ...

Metastatic stomach cancer is cancer that has spread beyond your stomach to distant tissues. Treatment generally focuses on extending your life and reducing symptoms. Metastatic stomach cancer is ...